Factors Influencing Relapse After Omalizumab in Chronic Urticaria. Does the Method of Discontinuation Influence Relapse?
Introduction: Omalizumab is recommended until spontaneous remission occurs rather than for a specific period of time in chronic urticaria (CU). The rate of recurrence of symptoms after treatment varies depending on the method of discontinuation. Objectives: Our study aimed to investigate how the...
| Published in: | Dermatology Practical & Conceptual |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Mattioli1885
2025-07-01
|
| Subjects: | |
| Online Access: | https://dpcj.org/index.php/dpc/article/view/5196 |